| Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies M Scully, S Cataland, P Coppo, J De La Rubia, KD Friedman, JK Hovinga, ... Journal of thrombosis and haemostasis 15 (2), 312-322, 2017 | 441 | 2017 |
| Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura SR Cataland, PJ Kourlas, S Yang, S Geyer, L Witkoff, H Wu, C Masias, ... Blood Advances 1 (23), 2075-2082, 2017 | 76 | 2017 |
| Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD SA Wall, Q Zhao, M Yearsley, L Blower, A Agyeman, P Ranganathan, ... Blood advances 2 (20), 2619-2628, 2018 | 56 | 2018 |
| Optimized synthesis of biodegradable elastomer pegylated poly (glycerol sebacate) and their biomedical application Y Wang, H Wu, Z Wang, J Zhang, J Zhu, Y Ma, Z Yang, Y Yuan Polymers 11 (6), 965, 2019 | 51 | 2019 |
| Microfluidic-based single-cell study: current status and future perspective H Wu, J Zhu, Y Huang, D Wu, J Sun Molecules 23 (9), 2347, 2018 | 43 | 2018 |
| No major differences in outcomes between the initial and relapse episodes in patients with thrombotic thrombocytopenic purpura: The experience from the Ohio State University … C Masias, H Wu, M McGookey, L Jay, S Cataland, S Yang American Journal of Hematology 93 (3), E73-E75, 2018 | 14 | 2018 |
| A prospective, randomized study of cyclosporine or corticosteroids as an adjunct to plasma exchange for the treatment of thrombotic thrombocytopenic purpura S Cataland, S Yang, CM Castanon, M McGookey, H Wu, S Geyer, ... Blood 128 (22), 133, 2016 | 11 | 2016 |
| Interrelationship between ADAMTS13 activity, von Willebrand factor, and complement activation in remission from immune‐mediated trhrombotic thrombocytopenic purpura. H Wu, L Jay, S Lin, C Han, S Yang, SR Cataland, C Masias British Journal of Haematology 189 (1), 2020 | 8 | 2020 |
| Severely deficient ADAMTS13 activity predicts relapse of immune-mediated thrombotic thrombocytopenic purpura in pregnancy C Masias, K Carter, H Wu, S Yang, A Flowers, S Cataland Blood 134, 1098, 2019 | 3 | 2019 |
| Relapse prediction model for immune-mediated thrombotic thrombocytopenic purpura C Masias, S Yang, S Sukumar, A Flowers, H Wu, K Carter, S Lin, C Han, ... Blood 136, 8-9, 2020 | 1 | 2020 |
| Complement is Activated via the Classical Pathway (CP) in Patients with Gastrointestinal Graft Versus Host Disease (GI GVHD) S Wall, L Blower, M Yearsley, Q Zhao, A Agyeman, P Ranganathan, ... Biology of Blood and Marrow Transplantation 24 (3), S182-S183, 2018 | 1 | 2018 |
| A Multi-Center, Randomized Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Initial Therapy of Thrombotic Thrombocytopenic Purpura P Chairman, S Cataland, P Co-Chairman, H Wu | 1 | 2015 |
| The effect of ZnMoS4 NPs on tumor angiogenesis H Wu Kent State University, 2014 | 1 | 2014 |
| Inhibition of vascular endothelial cell tube formation by zinc nanoparticles. VS Perera, H Wu, LD Yang, SD Huang, GC Fraizer Cancer Research 73 (8_Supplement), 1615-1615, 2013 | 1 | 2013 |
| The pivotal role of glutathione reductase in host defense against Gram-negative bacteria (111.25) J Yan, X Meng, L Wancket, K Lintner, H Wu, L Nelin, B Chen, C Smith, ... The Journal of Immunology 186 (1_Supplement), 111.25-111.25, 2011 | 1 | 2011 |
| Protein-based RBD-C-tag COVID-19 Vaccination Candidate Elicits Protection Activity against SARS-COV-2 Variant Infection J Subramani, N Shaabani, D Shetty, H Wu, S Kwon, W Li, C Yue, C Lahtz, ... bioRxiv, 2021.08. 17.456704, 2021 | | 2021 |
| A Pilot Study on Biomarkers of Vascular Injury in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura C Masias, R Tarawneh, H Wu, K Carter, S Yang, A Flowers, M Scully, ... Blood 134, 2377, 2019 | | 2019 |
| Prediction of Relapse Based on Remission ADAMTS13 Activity in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura CM Castanon, C Stevens, L Jay, H Wu, M McGookey, J Chen, JN George, ... Blood 130, 4843, 2017 | | 2017 |
| No Major Differences in Outcomes Between the Initial and Relapse Episodes in Patients with Thrombotic Thrombocytopenic Purpura: The Experience from the Ohio State University … CM Castanon, H Wu, M McGookey, L Jay, H Wu, SR Cataland, S Yang Blood 128 (22), 2544, 2016 | | 2016 |
| Genotype and phenotype features of congenital thrombotic thrombocytopenic purpura patients (milan TTP registry) A Cairo, I Mancini, G Casoli, A Artoni, B Ferrari, H Wu, F Peyvandi JOURNAL OF THROMBOSIS AND HAEMOSTASIS 13, 476-476, 2015 | | 2015 |
